4‐Octyl Itaconate Attenuates Age‐Induced Parotid Gland Dysfunction Through the Suppression of Fibrosis and Lipid Deposition by AMPKα/PPARα and the Inhibition of Oxidative Stress via the AMPKα/Nrf2 Signaling Pathway
Treatment with 4‐OI improved the aging of the parotid gland by increasing gland FAO, decreasing gland fibrosis, and preventing oxidative reactions, and upregulating the AMPKα/Nrf2 and AMPKα/PPARα signaling pathways.